This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Addus HomeCare Corporation (Nasdaq: ADUS) has closed its $350 million acquisition of Gentiva’s personalcare business. Gentiva’s personalcare segment brings in annual revenues of close to $280.0 Notably, we will now be the largest provider of personalcare services in the state of Texas,” Allison said. “We
Addus HomeCare Corporation (NASDAQ: ADUS) has entered into a definitive agreement to acquire Gentiva’s personalcare business for about $350 million. Gentiva’s personalcare segment brings in annual revenues of close to $280.0 CDR in 2022 purchased a 60% stake from the insurance mammoth Humana, Inc.,
Though the acquisition market has slowed down this year for home-based care companies, Addus HomeCare Corp. The most prominent home-based care transactions so far this year have involved payers seeking to acquire large providers with multiple business lines. NASDAQ: ADUS) remains on the hunt.
Addus HomeCare Corp. The company is seeking to pair its clinical services with its personal business in its existing markets. The personalcare, hospice and home health provider is no stranger to acquisitions. for $85 million in October 2022 and picked up Chicago-based Apple Home Health Ltd.
As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personalcare services, with hospice becoming less of a priority.
Addus HomeCare Corporation’s (NASDAQ: ADUS) is shifting its M&A strategy away from hospice deals to focus on its home health and personalcare businesses. Texas-based Addus provides personal, home health and hospice care across 207 locations in 22 states, reaching roughly 46,500 patients annually.
In 2022, the hospice community laid the groundwork for a transformational 2023. During late 2021 and 2022, the U.S. These were some of the key themes in the most-read Hospice News articles of 2022 that centered around the merger and acquisition landscape as well as the regulatory climate. 3–6 Big Provider, Payer Hospice Deals.
Addus HomeCare Corporation’s (NASDAQ: ADUS) hospice segment is seeing slow but steady improvement as pandemic headwinds ease. Meanwhile, the company’s near-term acquisition sights are set more on home health than in personalcare amid potential payment shifts. Its personalcare services arm reached $190.03
Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. The agreement marked not only one of the largest deals in hospice, but also signaled increasing interest among payers to operate health care provider companies.
In 2022, more than 907,000 Medicare hospice decedents were older than 85, out of 1.7 million total patients, according to the National Alliance for Care at Home. Its parent organization also operates senior living, pharmacy, development, independent living, personalcare, assisted living and memory care businesses, among others.
Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. Only three hospice deals took place in the third quarter of this year compared to 11 in Q3 2022 and 18 in the same period in 2021, according to data from the M&A advisory firm The Braff Group.
Addus HomeCare Corp. NASDAQ: ADUS) has reached an agreement to purchase the home health, hospice and private duty operator Tennessee Quality Care for $106 million. Tennessee Quality Care operates 17 locations serving an average of 1,800 patients daily throughout 50 of the 95 counties in its home state.
Acquisitions will be crucial to Addus HomeCare Corp.’s s (NASDAQ: ADUS) 2022 objectives as COVID headwinds start to abate. Addus CFO and executive vice president Brian Poff indicated that the company is in a “favorable position to continue to be acquisitive,” in a Q1 2022 earnings call.“.
billion , which closed at the end of 2022. The industry could see similar deals take shape as payers increasingly recognize the value of having a foothold in home-based care, he indicated. billion divestiture of a 60% stake in Kindred at Home’s hospice and personalcare segments. s (NYSE: HUM) $2.8
Addus HomeCare Corp. NASDAQ: ADUS) has completed the acquisition of the home health, hospice, and private-duty company Tennessee Quality Care for an undisclosed amount. All told, Addus provides hospice, home health and personalcare to an estimated 47,500 patients annually across 203 locations in 22 states. Census Bureau.
Gentiva’s recent $710 million acquisition of ProMedica’s hospice and home-based care assets bucks prevailing trends in today’s M&A market. Transaction volume dipped during 2022, specifically when it came to large platform deals by private equity firms. billion divestiture of Kindred at Home’s hospice and personalcare segments.
Staffing improvements and reimbursement shifts are paving Addus HomeCare’s (NASDAQ: ADUS) growth path this year. That path will divert more toward home health and personalcare – and less in the direction of hospice – as 2023 progresses. million in revenue for all of 2022. Its personalcare services reached $183.4
Addus plans to stay busy in the acquisitions market in the latter half of the year into early 2023, targeting primarily personalcare and home health deals, according to CEO Dirk Allison. Since 2019, Addus has purchased seven personalcare companies and four home health and hospice agencies.
High valuations have led Addus HomeCare (NASDAQ: ADUS) to pivot towards personalcare and home health deals rather than hospice acquisitions. Hospice multiples broke records in 2020, 2021 and 2022, reaching as high as 29x. Addus began as a personalcare provider in 1979. million during Q4 2022, about 20.5%
Addus HomeCare Corp. The company anticipates growth in its personalcare business in 2024, which will have a reverberating impact in its hospice and home health service lines. for $85 million in October 2022 and picked up Chicago-based Apple Home Health Ltd. jump compared to the same period in 2022. million.
Many companies are focused on bolstering their nursing workforce, who are also in high demand, but providers also need to prioritize hiring a sufficient number of aides, according to Cooper Linton, associate vice president of Duke HomeCare & Hospice. Bureau of Labor Statistics (BLS) report. However, this may not be enough.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content